A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma
Incyte Corporation
Incyte Corporation
Pfizer
Alpha Tau Medical LTD.
Novartis
Turnstone Biologics, Corp.
Apexigen America, Inc.
Clinigen, Inc.
Nektar Therapeutics
Bristol-Myers Squibb
Idera Pharmaceuticals, Inc.
Exicure, Inc.
Barco NV
Dynavax Technologies Corporation
Clinigen, Inc.
Celldex Therapeutics
Aprea Therapeutics
sigma-tau i.f.r. S.p.A.
MELA Sciences, Inc.
Calando Pharmaceuticals
DUSA Pharmaceuticals, Inc.
Thallion Pharmaceuticals